FR2123278A1 - - Google Patents

Info

Publication number
FR2123278A1
FR2123278A1 FR7145543A FR7145543A FR2123278A1 FR 2123278 A1 FR2123278 A1 FR 2123278A1 FR 7145543 A FR7145543 A FR 7145543A FR 7145543 A FR7145543 A FR 7145543A FR 2123278 A1 FR2123278 A1 FR 2123278A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7145543A
Other languages
French (fr)
Other versions
FR2123278B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Pharmaceuticals Ltd
Astra USA Inc
Original Assignee
Astra Pharmaceuticals Ltd
Astra Pharmaceutical Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharmaceuticals Ltd, Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceuticals Ltd
Publication of FR2123278A1 publication Critical patent/FR2123278A1/fr
Application granted granted Critical
Publication of FR2123278B1 publication Critical patent/FR2123278B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7145543A 1971-01-26 1971-12-17 Expired FR2123278B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10994271A 1971-01-26 1971-01-26

Publications (2)

Publication Number Publication Date
FR2123278A1 true FR2123278A1 (enExample) 1972-09-08
FR2123278B1 FR2123278B1 (enExample) 1975-08-01

Family

ID=22330411

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7145542A Expired FR2123277B1 (enExample) 1971-01-26 1971-12-17
FR7145543A Expired FR2123278B1 (enExample) 1971-01-26 1971-12-17

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR7145542A Expired FR2123277B1 (enExample) 1971-01-26 1971-12-17

Country Status (18)

Country Link
AT (2) AT310938B (enExample)
AU (1) AU465875B2 (enExample)
BE (2) BE776769A (enExample)
BR (2) BR7108429D0 (enExample)
CA (2) CA986012A (enExample)
DD (2) DD96144A5 (enExample)
DE (2) DE2163054C3 (enExample)
DK (2) DK130389B (enExample)
ES (2) ES398108A1 (enExample)
FR (2) FR2123277B1 (enExample)
GB (1) GB1370904A (enExample)
HU (2) HU162185B (enExample)
IE (2) IE35937B1 (enExample)
LU (1) LU64664A1 (enExample)
NL (2) NL7117401A (enExample)
NO (2) NO135891C (enExample)
SE (2) SE391286B (enExample)
ZA (2) ZA718326B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
WO1998051290A2 (en) * 1997-05-16 1998-11-19 Children's Medical Center Corporation Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent
RU2277097C1 (ru) * 2004-12-27 2006-05-27 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Высокомеченный тритием дигидрохлорид [3h]сакситоксина
CN101563079B (zh) 2006-03-27 2012-12-05 威克斯药业有限公司 钠通道阻滞剂在制备治疗由于化疗而产生的神经病理性疼痛的药物中的用途
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
KR20210062693A (ko) 2013-03-15 2021-05-31 더 칠드런스 메디칼 센터 코포레이션 지속성 국소 마취용 네오삭시톡신 조합 제형

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917894A (en) * 1988-06-29 1990-04-17 Beecham Inc. Rapid-onset long-duration oral anesthetic composition

Also Published As

Publication number Publication date
BR7108428D0 (pt) 1973-06-14
DK131606B (da) 1975-08-11
DD96144A5 (enExample) 1973-03-12
DE2163054B2 (de) 1978-06-01
BE776768A (fr) 1972-06-16
HU162185B (enExample) 1973-01-29
AT310938B (de) 1973-10-25
AU3710171A (en) 1973-06-28
IE35910L (en) 1972-07-26
ES398109A1 (es) 1975-03-16
ZA718326B (en) 1972-09-27
SE391127B (sv) 1977-02-07
DK131606C (da) 1976-01-12
DD96400A5 (enExample) 1973-03-20
FR2123277B1 (enExample) 1975-06-13
NO135892C (no) 1978-05-16
DE2163054A1 (de) 1974-05-02
BR7108429D0 (pt) 1973-06-14
DK130389C (enExample) 1975-07-14
DE2163055A1 (de) 1972-10-12
HU162347B (enExample) 1973-02-28
NO135892B (enExample) 1977-03-14
IE35937L (en) 1972-07-26
IE35910B1 (en) 1976-06-23
IE35937B1 (en) 1976-07-07
FR2123277A1 (enExample) 1972-09-08
BE776769A (fr) 1972-06-16
AU3710071A (en) 1973-06-28
NL7117401A (enExample) 1972-07-28
DK130389B (da) 1975-02-17
NO135891C (no) 1978-05-16
ZA718327B (en) 1972-09-27
NL7117404A (enExample) 1972-07-28
GB1370904A (en) 1974-10-16
FR2123278B1 (enExample) 1975-08-01
ES398108A1 (es) 1975-03-01
NO135891B (enExample) 1977-03-14
CA986012A (en) 1976-03-23
AU465875B2 (en) 1975-10-09
SE391286B (sv) 1977-02-14
DE2163054C3 (de) 1979-02-01
AT310939B (de) 1973-10-25
LU64664A1 (enExample) 1972-08-23
CA983850A (en) 1976-02-17

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
FR2123277A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2941471A (enExample)
AU2564071A (enExample)
AU2894671A (enExample)
AU2742671A (enExample)
AU2726271A (enExample)
AU2952271A (enExample)
AU2684071A (enExample)
AU3005371A (enExample)
AU2485671A (enExample)
AU2473671A (enExample)
AU2755871A (enExample)
AU2503871A (enExample)
AU2486471A (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU3038671A (enExample)
AU2669471A (enExample)
AU2927871A (enExample)
AU2684171A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse